Concepedia

Sarah Shandrick

SS

10

Publications

425

Citations

10

H-Index

2001

Active since

Affiliations

Torrey Pines Institute For Molecular Studies(Current)

BioCryst Pharmaceuticals (United States)

Genesys (United States)

Sunesis (United States)

Arena Pharmaceuticals (United States)

Sarah Shandrick is an author at Torrey Pines Institute For Molecular Studies specializing in molecular biology, medicine, and biochemistry.

Top concepts

Publications per year

2001–2004

10

Publications

10

Monitoring Molecular Recognition of the Ribosomal Decoding Site

Sarah Shandrick, Qiang Zhao, Qing Han et al. · Angewandte Chemie International Edition · 2004 · 127 citations

, , +18

Novel Paromamine Derivatives Exploring Shallow-Groove Recognition of Ribosomal- Decoding-Site RNA

Klaus B. Simonsen, Benjamin K. Ayida, Dionisios Vourloumis et al. · ChemBioChem · 2002 · 49 citations

Novel 2,5-dideoxystreptamine derivatives targeting the ribosomal decoding site RNA

Dionisios Vourloumis, Masayuki Takahashi, Geoffrey C. Winters et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 49 citations

, , +1

Rational design of azepane-glycoside antibiotics targeting the bacterial ribosome

Sofía Barluenga, Klaus B. Simonsen, Ethel S. Littlefield et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 48 citations

, , +4

Aminoglycoside‐Hybrid Ligands Targeting the Ribosomal Decoding Site

Dionisios Vourloumis, Geoffrey C. Winters, Klaus B. Simonsen et al. · ChemBioChem · 2004 · 38 citations

, , +12

Rows per page

1–5 of 10